Uptake of colorectal cancer screening: System, provider and individual factors and strategies to improve participation

Future Oncology

Volumn 5, Issue 9, 2009, Pages 1371-1388

  Power, Emily ^a   Miles, Anne ^a   Von Wagner, Christian ^a   Robb, Katie ^a   Wardle, Jane ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Colorectal cancer; Disparities; Ethnicity; Participation; Psychosocial; Review; Screening; Socio economic status

Indexed keywords

AGE; ATTITUDE TO ILLNESS; AWARENESS; CANCER INCIDENCE; CANCER MORTALITY; CANCER SCREENING; CANCER STAGING; CLINICAL ASSESSMENT TOOL; CLINICAL TRIAL; COLON ADENOMA; COLON POLYP; COLORECTAL CANCER; DIAGNOSTIC TEST; EDUCATION PROGRAM; EDUCATIONAL STATUS; ETHNICITY; FEAR; HEALTH CARE ACCESS; HEALTH CARE DELIVERY; HEALTH CARE PLANNING; HEALTH INSURANCE; HEALTH PROGRAM; HEALTH PROMOTION; HEALTH SURVEY; HUMAN; IMMUNOHISTOCHEMISTRY; OCCULT BLOOD; PATIENT ATTITUDE; PATIENT CARE PLANNING; PATIENT COMPLIANCE; PATIENT PARTICIPATION; POLYPECTOMY; PRACTICE GUIDELINE; PRECANCER; PRIORITY JOURNAL; PROGRAM DEVELOPMENT; PUBLIC HEALTH SERVICE; REVIEW; RISK FACTOR; RISK MANAGEMENT; RISK REDUCTION; SEX DIFFERENCE; SIGMOIDOSCOPY; SOCIAL STATUS; ATTITUDE TO HEALTH; CLINICAL PRACTICE; COLORECTAL TUMOR; MASS SCREENING;

COLORECTAL NEOPLASMS; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTH PLAN IMPLEMENTATION; HUMANS; MASS SCREENING; PATIENT COMPLIANCE; PATIENT PARTICIPATION; PHYSICIAN'S PRACTICE PATTERNS;

EID: 74949140900     PISSN: 14796694     EISSN: 17448301     Source Type: Journal    
DOI: 10.2217/fon.09.134     Document Type: Review

References (189)

1. Ferlay J, Bray F, Pisani P, Parkin DM: GLOBOCAN 2002: Cancer incidence, mortality and prevalence worldwide. International Agency for Research on Cancer Press, Lyon, France, 5, Version 2.0 (2004).
2. US Preventive Services Task Force: Screening for colorectal cancer: US Preventive Services Task Force recommendation statement. Ann. Behav. Med. 149, 627-637 (2008).
3. Winawer SJ: Colorectal cancer screening. Best Pract. Res. Clin. Gastroenterol. 21(6), 1031-1048 (2007).
4. Hewitson P, Glasziou P, Irwig L, Towler B, Watson E: Screening for colorectal cancer using the faecal occult blood test, Hemoccult. Cochrane Database Syst. Rev.1, CD001216 (2007).
5. Atkin WS, Edwards R, Wardle J et al.: Design of a multicentre randomized trial to evaluate flexible sigmoidoscopy in colorectal cancer screening. J. Med. Screen. 8(3), 137-144 (2001).
6. Gondal G, Grotmol T, Hofstad B, Bretthauer M, Eide TJ, Hoff G: The Norwegian Colorectal Cancer Prevention (NORCCAP) screening study. Scand. J. Gastroenterol. 38(6), 635-642 (2003).
7. Segnan N, Senore C, Andreoni B et al.: Baseline findings of the Italian multicenter randomized controlled trial of 'Once-only sigmoidoscopy' - SCORE. J. Natl. Cancer Inst. 94(23), 1763-1772 (2002).
8. Prorok PC, Andriole GL, Bresalier RS et al.: Design of the Prostate, Lung, Colorectal and Ovarian (PLCO) cancer screening trial. Control. Clin. Trials 21(6), S273-S309 (2000).
9. Hoff G, Grotmol T, Skovlund E, Bretthauer M: Risk of colorectal cancer seven years after flexible sigmoidoscopy screening: randomized controlled trial. Br. Med. J. 338, B1846 (2009).
10. Thiis-Evensen E, Hoff GS, Sauar J, Langmark F, Majak BM, Vatn MH: Population-based surveillance by colonoscopy: effect on the incidence of colorectal cancer. Telemark Polyp Study I. Scand. J. Gastroenterol. 34(4), 414-420 (1999).
11. Muller AD, Sonnenberg A: Prevention of colorectal-cancer by flexible endoscopy and polypectomy - a case-control study of 32702 veterans. Ann. Intern. Med. 123(12), 904 (1995).
12. Newcomb PA, Norfleet RG, Storer BE, Surawicz TS, Marcus PM: Screening sigmoidoscopy and colorectal-cancer mortality. J. Natl. Cancer Inst. 84(20), 1572-1575 (1992).
13. Selby JV, Friedman GD, Quesenberry CP Jr, Weiss NS: A case-control study of screening sigmoidoscopy and mortality from colorectal cancer. N. Engl. J. Med. 326(10), 653-657 (1992).
14. Brenner H, Arndt V, Sturmer T, Stegmaier C, Zieger H, Dhom G: Long-lasting reduction of risk of colorectal cancer following screening endoscopy. Br. J. Cancer 85(7), 972-976 (2001).
15. Winawer SJ, Zauber AG, Ho MN et al.: Prevention of colorectal-cancer by colonoscopic polypectomy. N. Engl. J. Med. 329(27), 1977-1981 (1993).
16. Benson VS, Patnick J, Davies AK, Nadel MR, Smith RA, Atkin WS: Colorectal cancer screening: a comparison of 35 initiatives in 17 countries. Int. J. Cancer 122(6), 1357-1367 (2008).
17. International Screening Network: Inventory of Colorectal Cancer Screening Activities in ICSN Countries. National Cancer Institute (2008).
18. Khandker RK, Dulski JD, Kilpatrick JB, Ellis RP, Mitchell JB, Baine WB: A decision model and cost-effectiveness ana lysis of colorectal cancer screening and surveillance guidelines for average-risk adults. Int. J. Technol. Assess. Health Care 16(3), 799-810 (2000).
19. Lieberman DA: Cost-effectiveness model for colon cancer screening. Gastroenterology 109(6), 1781-1790 (1995).
20. Sonnenberg A, Delco F, Inadomi JM: Cost-effectiveness of colonoscopy in screening for colorectal cancer. Ann. Intern. Med. 133(8), 573-584 (2000).
21. Seifert B, Zavoral M, Fric P, Bencko V: The role of primary care in colorectal cancer screening: experience from Czech Republic. Neoplasma 55(1), 74-80 (2008).
22. Malila N, Oivanen T, Hakama M: Implementation of colorectal cancer screening in Finland: experiences from the first three years of a public health programme. Z. Gastroenterol. 46, S25-S28 (2008).
23. Zorzi M, Barca A, Falcini F et al.: Screening for colorectal cancer in Italy: 2005 survey. Epidemiol. Prev. 31(2-3), 49-60 (2007).
24. Goulard H, Boussac-Zarebska M, Ancelle-Park R, Bloch J: French colorectal cancer screening pilot programme: results of the first round. J. Med. Screen. 15(3), 143-148 (2008).
25. Brotherstone H, Vance M, Edwards R et al.: Uptake of population-based flexible sigmoidoscopy screening for colorectal cancer: a nurse-led feasibility study. J. Med. Screen. 14(2), 76-80 (2007).
26. Meissner HI, Breen N, Klabunde CN, Vernon SW: Patterns of colorectal cancer screening uptake among men and women in the United States. Cancer Epidemiol. Biomarkers Prev. 15(2), 389-394 (2006).
27. Centers for Disease Control and Prevention: National Health Interview Survey public use data file 2005. National Center for Health Statistics (2006).
28. Lafata JE, Williams LK, Ben-Menachem T, Moon C, Divine G: Colorectal carcinoma screening procedure use among primary care patients. Cancer 104(7), 1356-1361 (2005).
29. Liang SY: Rates and predictors of colorectal cancer screening. Prev. Chronic Dis. 3(4), A117 (2006).
30. Neilson AR, Whynes DK: Determinants of persistent compliance with screening for colorectal cancer. Soc. Sci. Med. 41(3), 365-374 (1995).
31. O'Malley AS, Forrest CB, Feng S, Mandelblatt J: Disparities despite coverage: gaps in colorectal cancer screening among Medicare beneficiaries. Arch. Intern. Med. 165(18), 2129-2135 (2005).
32. Weller D, Coleman D, Robertson R et al.: The UK colorectal cancer screening pilot: results of the second round of screening in England. Br. J. Cancer 97(12), 1601-1605 (2007).
33. McCaffery K, Wardle J, Nadel M, Atkin W: Socioeconomic variation in participation in colorectal cancer screening. J. Med. Screen. 9(3), 104-108 (2002).
34. Power E, van Jaarsveld CHM, McCaffery K, Miles A, Atkin W, Wardle J: Understanding intentions and action in colorectal cancer screening. Ann. Behav. Med. 35(3), 285-294 (2008).
35. Wardle J, McCaffery K, Nadel M, Atkin W: Socioeconomic differences in cancer screening participation: comparing cognitive and psychosocial explanations. Soc. Sci. Med. 59(2), 249-261 (2004).
36. Berkowitz Z, Hawkins NA, Peipins LA, White MC, Nadel MR: Beliefs, risk perceptions, and gaps in knowledge as barriers to colorectal cancer screening in older adults. J. Am. Geriatr. Soc. 56(2), 307-314 (2008).
37. Weber MF, Banks E, Ward R, Sitas F: Population characteristics related to colorectal cancer testing in New South Wales, Australia: results from the 45 and Up Study cohort. J. Med. Screen. 15(3), 137-142 (2008).
38. Davis TC, Dolan NC, Ferreira MR et al.: The role of inadequate health literacy skills in colorectal cancer screening. Cancer Invest. 19(2), 193-200 (2001).
39. Paasche-Orlow MK, Wolf MS: The causal pathways linking health literacy to health outcomes. Am. J. Health Behav. 31(Suppl. 1), S19-S26 (2007).
40. von Wagner C, Knight K, Steptoe A, Wardle J: Functional health literacy and health-promoting behavior in a national sample of British adults. J. Epidemiol. Community Health 61(12), 1086-1090 (2007).
41. Post DM, Katz ML, Tatum C, Dickinson SL, Lemeshow S, Paskett ED: Determinants of colorectal cancer screening in primary care. J. Cancer Educ. 23(4), 241-247 (2008).
42. Tessaro I: Knowledge, barriers, and predictors of colorectal cancer screening in an Appalachian church population. Prev. Chronic Dis. 3(4), A123 (2006).
43. Zimmerman RK, Nowalk MP, Tabbarah M, Grufferman S: Predictors of colorectal cancer screening in diverse primary care practices. BMC Health Serv. Res. 6, 116 (2006).
44. Sutton S, Wardle J, Taylor T et al.: Predictors of attendance in the United Kingdom flexible sigmoidoscopy screening trial. J. Med. Screen. 7(2), 99-104 (2000).
45. Griffith KA, McGuire DB, Royak-Schaler R, Plowden KO, Steinberger EK: Influence of family history and preventive health behaviors on colorectal cancer screening in African-Americans. Cancer 113(2), 276-285 (2008).
46. McCarthy BD, Moskowitz MA: Screening flexible sigmoidoscopy: patient attitudes and compliance. J. Gen. Intern. Med. 8(3), 120-125 (1993).
47. Deutekom M, van Rijn AF, Dekker E et al.: Uptake of faecal occult blood test colorectal cancer screening by different ethnic groups in the Netherlands. Eur. J. Public Health 19(4), 400-402 (2009).
48. Ananthakrishnan AN, Schellhase KG, Sparapani RA, Laud PW, Neuner JM: Disparities in colon cancer screening in the Medicare population. Arch. Intern. Med. 167(3), 258-264 (2007).
49. Peterson NB, Murff HJ, Ness RM, Dittus RS: Colorectal cancer screening among men and women in the United States. J. Womens Health (Larchmt) 16(1), 57-65 (2007).
50. Seeff LC, Nadel MR, Klabunde CN et al.: Patterns and predictors of colorectal cancer test use in the adult US population. Cancer 100(10), 2093-2103 (2004).
51. Wee CC, McCarthy EP, Phillips RS: Factors associated with colon cancer screening: the role of patient factors and physician counseling. Prev. Med. 41(1), 23-29 (2005).
52. Robb KA, Power E, Atkin W, Wardle J: Ethnic differences in participation in flexible sigmoidoscopy screening in the UK. J. Med. Screen. 15(3), 130-136 (2008).
53. Szczepura A, Price C, Gumber A: Breast and bowel cancer screening uptake patterns over 15 years for UK south Asian ethnic minority populations, corrected for differences in socio-demographic characteristics. BMC Public Health 8, 346 (2008).
54. Carozza SE, Howe HL: Patterns of cancer incidence among US Hispanics/Latinos, 1995-2000. Cancer Causes Control 17(8), 1067-1075 (2006).
55. Grulich AE, Swerdlow AJ, Head J, Marmot MG: Cancer mortality in African and Caribbean migrants to England and Wales. Br. J. Cancer 66(5), 905-911 (1992).
56. Winter H, Cheng KK, Cummins C, Maric R, Silcocks P, Varghese C: Cancer incidence in the south Asian population of England (1990-1992). Br. J. Cancer 79(3-4), 645-654 (1999).
57. Yang RC, Mills PK: Proportionate cancer incidence in the Laotian population of California, 1988-2006. Cancer Causes Control 20(6), 1011-1016 (2009).
58. Cardarelli R, Thomas JE: Having a personal health care provider and receipt of colorectal cancer testing. Ann. Fam. Med. 7(1), 5-10 (2009).
59. Segnan N, Senore C, Andreoni B et al.: Randomized trial of different screening strategies for colorectal cancer: patient response and detection rates. J. Natl. Cancer Inst. 97(5), 347-357 (2005).
60. Jerant AF: Age-related disparities in cancer screening: ana lysis of 2001 Behavioral Risk Factor Surveillance System data. Ann. Fam. Med. 2(5), 481-487 (2004).
61. Brenner H, Hoffmeister M, Brenner G, Altenhofen L, Haug U: Expected reduction of colorectal cancer incidence within 8 years after introduction of the German screening colonoscopy programme: estimates based on 1,875,708 screening colonoscopies. Eur. J. Cancer 45(11), 2027-2033 (2009).
62. Sheinfeld GS, Gauthier J, Hay J, Miles A, Wardle J: Cancer screening and aging: research barriers and opportunities. Cancer 113(12 Suppl.), 3493-3504 (2008).
63. Centers for Disease Control and Prevention: Use of colorectal cancer tests - United States, 2002, 2004, 2006. MMWR Morb. Mortal. Wkly Rep. 57(10), 253-258 (2008).
64. Blom J, Yin L, Liden A et al.: Toward understanding non participation in sigmoidoscopy screening for colorectal cancer. Int. J. Cancer 122(7), 1618-1623 (2008).
65. van Jaarsveld CHM, Miles A, Edwards R, Wardle J: Marriage and cancer prevention: does marital status and inviting both spouses together influence colorectal cancer screening participation? J. Med. Screen. 13(4), 172-176 (2006).
66. Eisinger F, Cals L, Calazel-Benque A et al.: Impact of organized programs on colorectal cancer screening. BMC Cancer 8, 104 (2008).
67. Federici A, Barca A, Baiocchi D et al.: Can colorectal cancer mass-screening organization be evidence-based? Lessons from failures: the experimental and pilot phases of the Lazio program. BMC Public Health 8, 318 (2008).
68. Verne JE, Aubrey R, Love SB, Talbot IC, Northover JM: Population based randomized study of uptake and yield of screening by flexible sigmoidoscopy compared with screening by faecal occult blood testing. Br. Med. J. 317(7152), 182-185 (1998).
69. Robinson MH, Berry DP, Vellacott KD, Moshakis V, Hardcastle JD: Screening for colorectal cancer. Lancet 342(8865), 241 (1993).
70. Berry DP, Clarke P, Hardcastle JD, Vellacott KD: Randomized trial of the addition of flexible sigmoidoscopy to faecal occult blood testing for colorectal neoplasia population screening. Br. J. Surg. 84(9), 1274-1276 (1997).
71. Elwood JM, Ali G, Schlup MM et al.: Flexible sigmoidoscopy or colonoscopy for colorectal screening: a randomized trial of performance and acceptability. Cancer Detect. Prev. 19(4), 337-347 (1995).
72. Church TR, Yeazel MW, Jones RM et al.: A randomized trial of direct mailing of fecal occult blood tests to increase colorectal cancer screening. J. Natl. Cancer Inst. 96(10), 770-780 (2004).
73. Goldberg D, Schiff GD, McNutt R, Furumoto-Dawson A, Hammerman M, Hoffman A: Mailings timed to patients' appointments: a controlled trial of fecal occult blood test cards. Am. J. Prev. Med. 26(5), 431-435 (2004).
74. Mant D, Fuller A, Northover J et al.: Patient compliance with colorectal cancer screening in general practice. Br. J. Gen. Pract. 42(354), 18-20 (1992).
75. Ore L, Hagoel L, Lavi I, Rennert G: Screening with faecal occult blood test (FOBT) for colorectal cancer: assessment of two methods that attempt to improve compliance. Eur. J. Cancer Prev. 10(3), 251-256 (2001).
76. Freedman J, Mitchell C: A simple strategy to improve patient adherence to outpatient fecal occult blood testing. J. Gen. Intern. Med. 9, 462-464 (1994).
77. Cole SR, Smith A, Wilson C, Turnbull D, Esterman A, Young GP: An advance notification letter increases participation in colorectal cancer screening. J. Med. Screen. 14(2), 73-75 (2007).
78. Ward E, Halpern M, Schrag N et al.: Association of insurance with cancer care utilization and outcomes. CA Cancer J. Clin. 58(1), 9-31 (2008).
79. Carcaise-Edinboro P, Bradley CJ: Influence of patient-provider communication on colorectal cancer screening. Med. Care 46(7), 738-745 (2008).
80. Roetzheim RG, Pal N, Tennant C et al.: Effects of health insurance and race on early detection of cancer. J. Natl. Cancer Inst. 91(16), 1409-1415 (1999).
81. Breen N, Wagener DK, Brown ML, Davis WW, Ballard-Barbash R: Progress in cancer screening over a decade: results of cancer screening from the 1987, 1992, and 1998 National Health Interview Surveys. J. Natl. Cancer Inst. 93(22), 1704-1713 (2001).
82. Coughlin SS, Thompson TD: Colorectal cancer screening practices among men and women in rural and nonrural areas of the United States, 1999. J. Rural Health 20(2), 118-124 (2004).
83. Gilbert A, Kanarek N: Colorectal cancer screening: physician recommendation is influential advice to Marylanders. Prev. Med. 41(2), 367-379 (2005).
84. James TM, Greiner KA, Ellerbeck EF, Feng C, Ahluwalia JS: Disparities in colorectal cancer screening: a guideline-based ana lysis of adherence. Ethn. Dis. 16(1), 228-233 (2006).
85. Fukuda Y, Nakamura K, Takano T: Reduced likelihood of cancer screening among women in urban areas and with low socio-economic status: a multilevel ana lysis in Japan. Public Health 119(10), 875-884 (2005).
86. Zapka JG, Lemon SC: Interventions for patients, providers, and health care organizations. Cancer 101(5), 1165-1187 (2004).
87. Sieverding M, Matterne U, Ciccarello L: Gender differences in FOBT use: evidence from a large German survey. Z. Gastroenterol. 46(Suppl. 1), S47-S51 (2008).
88. Matthews BA, Nattinger AB, Venkatesan T, Shaker R: Colorectal cancer screening among midwestern community-based residents: indicators of success. J. Community Health 32(2), 103-120 (2007).
89. O'Malley AS, Beaton E, Yabroff KR, Abramson R, Mandelblatt J: Patient and provider barriers to colorectal cancer screening in the primary care safety-net. Prev. Med. 39(1), 56-63 (2004).
90. Honda K, Kagawa-Singer M: Cognitive mediators linking social support networks to colorectal cancer screening adherence. J. Behav. Med. 29(5), 449-460 (2006).
91. Kelly RB, Shank JC: Adherence to screening flexible sigmoidoscopy in asymptomatic patients. Med. Care 30(11), 1029-1042 (1992).
92. Bastani R, Gallardo NV, Maxwell AE: Barriers to colorectal cancer screening among ethnically diverse high- and average-risk individuals. J. Psychosoc. Oncol. 19(3-4), 65-84 (2001).
93. Fernandez ME, Wippold R, Torres-Vigil I et al.: Colorectal cancer screening among Latinos from US cities along the Texas-Mexico border. Cancer Causes Control 19(2), 195-206 (2008).
94. Goodman MJ, Ogdie A, Kanamori MJ, Canar J, O'Malley AS: Barriers and facilitators of colorectal cancer screening among mid-Atlantic Latinos: focus group findings. Ethn. Dis. 16(1), 255-261 (2006).
95. Hoffman-Goetz L, Thomson MD, Donelle L: Reasons for declining colorectal cancer screening by older Canadians: a pilot study. J. Cancer Educ. 23(1), 32-36 (2008).
96. Lasser KE, Ayanian JZ, Fletcher RH, Good MD: Barriers to colorectal cancer screening in community health centers: a qualitative study of patients and their primary care providers. J. Gen. Intern. Med. 22, 112-113 (2007).
97. McCaffery K, Borril J, Williamson S et al.: Declining the offer of flexible sigmoidoscopy screening for bowel cancer: a qualitative investigation of the decision-making process. Soc. Sci. Med. 53(5), 679-691 (2001).
98. Palmer RC, Midgette LA, Dankwa I: Colorectal cancer screening and African-Americans: findings from a qualitative study. Cancer Control 15(1), 72-79 (2008).
99. Wackerbarth SB, Peters JC, Haist SA: Modeling the decision to undergo colorectal cancer screening - insights on patient preventive decision making. Med. Care 46(9), S17-S22 (2008).
100. Shokar NK, Vernon SW, Weller SC: Cancer and colorectal cancer: knowledge, beliefs, and screening preferences of a diverse patient population. Fam. Med. 37(5), 341-347 (2005).
101. Brawarsky P, Brooks DR, Mucci LA: Correlates of colorectal cancer testing in Massachusetts men and women. Prev. Med. 36(6), 659-668 (2003).
102. Christman LK, Abdulla R, Jacobsen PB et al.: Colorectal cancer screening among a sample of community health center attendees. J. Health Care Poor Underserved 15, 281-293 (2003).
103. Sewitch MJ, Fournier C, Ciampi A, Dyachenko A: Adherence to colorectal cancer screening guidelines in Canada. BMC Gastroenterology 7, 39 (2007).
104. McGregor SE, Hilsden RJ, Li FX, Bryant HE, Murray A: Low uptake of colorectal cancer screening 3 yr after release of national recommendations for screening. Am. J. Gastroenterol. 102(8), 1727-1735 (2007).
105. Jo AM, Maxwell AE, Wong WK, Bastani R: Colorectal cancer screening among underserved Korean-Americans in Los Angeles County. J. Immigr. Minor. Health 10(2), 119-26 (2008).
106. Nguyen BH, Mcphee SJ, Stewart SL, Doan HT: Colorectal cancer screening in Vietnamese-Americans. J. Cancer Educ. 23(1), 37-45 (2008).
107. Sung JJY, Choi SYP, Chan FKL, Ching JYL, Lau JTF, Griffiths S: Obstacles to colorectal cancer screening in Chinese: a study based on the Health Belief Model. Am. J. Gastroenterol. 103(4), 974-981 (2008).
108. Beeker C, Kraft JM, Southwell BG, Jorgensen CM: Colorectal cancer screening in older men and women: qualitative research findings and implications for intervention. J. Community Health 25(3), 263-278 (2000).
109. Brouse CH, Basch CE, Wolf RL, Shmukler C: Barriers to colorectal cancer screening: an educational diagnosis. J. Cancer Educ. 19(3), 170-173 (2004).
110. Goel V, Gray R, Chart P, Fitch M, Saibil S, Zdanowicz Y: Perspectives on colorectal cancer screening: a focus group study. Health Expect. 7, 51-60 (2004).
111. Greiner KA, Born W, Nollen N, Ahluwalia JS: Knowledge and perceptions of colorectal cancer screening among urban African-Americans. J. Gen. Intern. Med. 20(11), 977-983 (2005).
112. Ogedegbe G, Cassells AN, Robinson CM et al.: Perceptions of barriers and facilitators of cancer early detection among low-income minority women in community health centers. J. Natl Med. Assoc. 97(2), 162-170 (2005).
113. Weitzman ER, Zapka J, Estabrook B, Goins KV: Risk and reluctance: understanding impediments to colorectal cancer screening. Prev. Med. 32(6), 502-513 (2001).
114. Robb KA, Solarin I, Power E, Atkin W, Wardle J: Attitudes to colorectal cancer screening among ethnic minority groups in the UK. BMC Public Health 8, 34 (2008).
115. Emmons K, Puleo E, McNeill L, Bennett G, Chan S, Syngal S: Colorectal cancer screening awareness and intentions among low income, sociodemographically diverse adults under age 50. Cancer Causes Control 19(10), 1031-1041 (2008).
116. McCaffery K, Wardle J, Waller J: Knowledge, attitudes, and behavioral intentions in relation to the early detection of colorectal cancer in the United Kingdom. Prev. Med. 36(5), 525-535 (2003).
117. Harewood GC, Wiersema MJ, Melton LJ: A prospective, controlled assessment of factors influencing acceptance of screening colonoscopy. Am. J. Gastroenterol. 97(12), 3186-3194 (2002).
118. Cronan TA: Ethnic differences in colorectal cancer screening. J. Psychosoc. Oncol. 26(2), 63-86 (2008).
119. Vernon SW: Participation in colorectal cancer screening: a review. J. Natl. Cancer Inst. 89(19), 1406-1422 (1997).
120. Brewer NT, Chapman GB, Gibbons FX, Gerrard M, Mccaul KD: Meta-ana lysis of the relationship between risk perception and health behavior: the example of vaccination. Health Psychol. 26(2), 136-145 (2007).
121. Van Der Velde FW, Hooykaas C, Van Der Pligt J: Conditional versus unconditional risk estimates in models of AIDS-related risk behavior. Psychol. Health 12(1), 87-100 (1996).
122. Aiken LS, West SG, Woodward CK, Reno RR: Health beliefs and compliance with mammography-screening recommendations in asymptomatic women. Health Psychol. 13(2), 122-129 (1994).
123. Ronis DL: Conditional health threats - health beliefs, decisions, and behaviors among adults. Health Psychol. 11(2), 127-134 (1992).
124. Hay JLFJS, Klein D, Primavera LH, Buckley TR: Adherence to colorectal cancer screening in mammography-adherent older women. J. Behav. Med. 26(6), 553-576 (2003).
125. Kremers SPJ, Mesters I, Pladdet IE, van den Borne B, Stockbrugger RW: Participation in a sigmoidoscopic colorectal cancer screening program: a pilot study. Cancer Epidemiol. Biomarkers Prev. 9(10), 1127-1130 (2000).
126. Myers RE, Sifri R, Hyslop T et al.: A randomized controlled trial of the impact of targeted and tailored interventions on colorectal cancer screening. Cancer 110(9), 2083-2091 (2007).
127. Stockwell DH, Woo P, Jacobson BC et al.: Determinants of colorectal cancer screening in women undergoing mammography. Am. J. Gastroenterol. 98(8), 1875-1880 (2003).
128. Brenes GA, Paskett ED: Predictors of stage of adoption for colorectal cancer screening. Prev. Med. 31(4), 410-416 (2000).
129. Farmer MM: Predictors of colorectal cancer screening from patients enrolled in a managed care health plan. Cancer 112(6), 1230-1238 (2008).
130. Farraye FA, Wong M, Hurwitz S et al.: Barriers to endoscopic colorectal cancer screening: are women different from men? Am. J. Gastroenterol. 99(2), 341-349 (2004).
131. Lewis SF, Jensen NM: Screening sigmoidoscopy - factors associated with utilization. J. Gen. Intern. Med. 11(9), 542-544 (1996).
132. Sun WY, Basch CE, Wolf RL, Li XJ: Factors associated with colorectal cancer screening among Chinese-Americans. Prev. Med. 39(2), 323-329 (2004).
133. Denberg TD, Melhado TV, Coombes JM et al.: Predictors of nonadherence to screening colonoscopy. J. Gen. Intern. Med. 20(11), 989-995 (2005).
134. Friedemann-Sanchez G, Griffin JM, Partin MR: Gender differences in colorectal cancer screening barriers and information needs. Health Expect. 10(2), 148-160 (2007).
135. Costanza ME, Luckmann R, Stoddard AM et al.: Applying a stage model of behavior change to colon cancer screening. Prev. Med. 41(3-4), 707-719 (2005).
136. Nash D, Azeez S, Vlahov D, Schori M: Evaluation of an intervention to increase screening colonoscopy in an urban public hospital setting. J. Urban Health 83(2), 231-243 (2006).
137. Roetzheim RG, Pal N, Tennant C et al.: Effects of health insurance and race on early detection of cancer. J. Natl. Cancer Inst. 91(16), 1409-1415 (1999).
138. Nemeth LS, Nietert PJ, Ornstein SM: High performance in screening for colorectal cancer: a Practice Partner Research Network (PPRNet) case study. J. Am. Board Fam. Med. 22(2), 141-146 (2009).
139. Stone EG, Morton SC, Hulscher ME et al.: Interventions that increase use of adult immunization and cancer screening services: a meta-ana lysis. Ann. Intern. Med. 136(9), 641-651 (2002).
140. Crabtree BF, Miller WL, Aita VA, Flocke SA, Stange KC: Primary care practice organization and preventive services delivery: a qualitative ana lysis. J. Fam. Pract. 46(5), 403-409 (1998).
141. Vinker S, Nakar S, Rosenberg E, Kitai E: The role of family physicians in increasing annual fecal occult blood test screening coverage: a prospective intervention study. Isr. Med. Assoc. J. 4(6), 424-425 (2002).
142. Shea S, DuMouchel W, Bahamonde L: A meta-ana lysis of 16 randomized controlled trials to evaluate computer-based clinical reminder systems for preventive care in the ambulatory setting. J. Am. Med. Inform. Assoc. 3(6), 399-409 (1996).
143. Balas EA, Weingarten S, Garb CT, Blumenthal D, Boren SA, Brown GD: Improving preventive care by prompting physicians. Arch. Intern. Med. 160(3), 301-308 (2000).
144. Guerra CE: Barriers of and facilitators to physician recommendation of colorectal cancer screening. J. Gen. Intern. Med. 22(12), 1681-1688 (2007).
145. Sequist TD, Zaslavsky AM, Marshall R, Fletcher RH, Ayanian JZ: Patient and physician reminders to promote colorectal cancer screening: a randomized controlled trial. Arch. Intern. Med. 169(4), 364-371 (2009).
146. Sabatino SA, Habarta N, Baron RC et al.: Interventions to increase recommendation and delivery of screening for breast, cervical, and colorectal cancers by healthcare providers systematic reviews of provider assessment and feedback and provider incentives. Am. J. Prev. Med. 35(1 Suppl.), S67-S74 (2008).
147. Ferreira MR, Dolan NC, Fitzgibbon ML et al.: Health care provider-directed intervention to increase colorectal cancer screening among veterans: results of a randomized controlled trial. J. Clin. Oncol. 23(7), 1548-1554 (2005).
148. Jepson R, Clegg A, Forbes C, Lewis R, Sowden A, Kleijnen J: The determinants of screening uptake and interventions for increasing uptake: a systematic review. Health Technol. Assess. 4(14), I-VII, 100-133 (2000).
149. Hillman AL, Ripley K, Goldfarb N, Nuamah I, Weiner J, Lusk E: Physician financial incentives and feedback: failure to increase cancer screening in Medicaid managed care. Am. J. Public Health 88(11), 1699-1701 (1998).
150. Lane DS, Messina CR, Cavanagh MF, Chen JJ: A provider intervention to improve colorectal cancer screening in county health centers. Med. Care 46(9 Suppl. 1), S109-S116 (2008).
151. Walsh JM, Salazar R, Terdiman JP, Gildengorin G, Perez-Stable EJ: Promoting use of colorectal cancer screening tests. Can we change physician behavior? J. Gen. Intern. Med. 20(12), 1097-1101 (2005).
152. Davis DA, Thomson MA, Oxman AD, Haynes RB: Changing physician performance. A systematic review of the effect of continuing medical education strategies. J. Am. Med. Assoc. 274(9), 700-705 (1995).
153. Klabunde CN, Lanier D, Breslau ES et al.: Improving colorectal cancer screening in primary care practice: innovative strategies and future directions. J. Gen. Intern. Med. 22(8), 1195-1205 (2007).
154. Baron RC, Rimer BK, Breslow RA et al.: Client-directed interventions to increase community demand for breast, cervical, and colorectal cancer screening a systematic review. Am. J. Prev. Med. 35(1 Suppl.), S34-S55 (2008).
155. Elwood TW, Erickson A, Lieberman S: Comparative educational approaches to screening for colorectal cancer. Am. J. Public Health 68, 135-138 (1978).
156. Miller MF, Wong JG: Reducing financial barriers enhances the return rate of stool Hemoccult packets. Am. J. Med. Sci. 306(2), 98-100 (1993).
157. Wardle J, Williamson S, McCaffery K et al.: Increasing attendance at colorectal cancer screening: testing the efficacy of a mailed, psychoeducational intervention in a community sample of older adults. Health Psychol. 22(1), 99-105 (2003).
158. Davis TC, Williams MV, Marin E, Parker RM, Glass J: Health literacy and cancer communication. CA Cancer J. Clin. 52(3), 134-149 (2002).
159. Michielutte R, Bahnson J, Dignan MB, Schroeder EM: The use of illustrations and narrative text style to improve readability of a health education brochure. J. Cancer Educ. 7(3), 251-260 (1992).
160. Zapka JG, Lemon SC, Puleo E, Estabrook B, Luckmann R, Erban S: Patient education for colon cancer screening: a randomized trial of a video mailed before a physical examination. Ann. Intern. Med. 141(9), 683-692 (2004).
161. Kreuter MW, Green MC, Cappella JN et al.: Narrative communication in cancer prevention and control: a framework to guide research and application. Ann. Behav. Med. 33(3), 221-235 (2007).
162. Hinyard LJ, Kreuter MW: Using narrative communication as a tool for health behavior change: a conceptual, theoretical, and empirical overview. Health Educ. Behav. 34(5), 777-792 (2007).
163. Rimer BK, Glassman B: Is there a use for tailored print communications in cancer risk communication? J. Natl Cancer Inst. Monographs 25, 140-148 (1999).
164. Ling BS, Schoen RE, Trauth JM et al.: Physicians encouraging colorectal screening: a randomized controlled trial of enhanced office and patient management on compliance with colorectal cancer screening. Arch. Intern. Med. 169(1), 47-55 (2009).
165. Lairson DR, DiCarlo M, Myers RE et al.: Cost-effectiveness of targeted and tailored interventions on colorectal cancer screening use. Cancer 112(4), 779-788 (2008).
166. Basch CE, Wolf RL, Brouse CH et al.: Telephone outreach to increase colorectal cancer screening in an urban minority population. Am. J. Public Health 96(12), 2246-2253 (2006).
167. Dietrich AJ, Tobin JN, Cassells A et al.: Translation of an efficacious cancerscreening intervention to women enrolled in a Medicaid managed care organization. Ann. Fam. Med. 5(4), 320-327 (2007).
168. Ruffin MT, Fetters MD, Jimbo M: Preference-based electronic decision aid to promote colorectal cancer screening: results of a randomized controlled trial. Prev. Med. 45(4), 267-273 (2007).
169. Lewis CL, Brenner AT, Griffith JM, Pignone MP: The uptake and effect of a mailed multimodal colon cancer screening intervention: a pilot controlled trial. Implement Sci. 3, 32 (2008).
170. Denberg TD: Effect of a mailed brochure on appointment-keeping for screening colonoscopy: a randomized trial. Ann. Intern. Med. 145(12), 895-900 (2006).
171. Shankaran V, McKoy JM, Dandade N et al.: Costs and cost-effectiveness of a low-intensity patient-directed intervention to promote colorectal cancer screening. J. Clin. Oncol. 25(33), 5248-5253 (2007).
172. Wolf MS, Fitzner KA, Powell EF et al.: Costs and cost effectiveness of a health care provider-directed intervention to promote colorectal cancer screening among Veterans. J. Clin. Oncol. 23(34), 8877-8883 (2005).
173. Entwistle VA, Carter SM, Trevena L et al.: Communicating about screening. Br. Med. J. 337, a1591 (2008).
174. Hofbauer F, Mach K, Egermann G: Repeat mass screening for fecal occult blood for the diagnosis of colorectal neoplasms in a rural district. Results of an informational campaign. Wien. Klin. Wochenschr. 103(10), 288-295 (1991).
175. Haidinger G, Waldhoer T, Vutuc C: Self-reported colonoscopy screening in Austria. Eur. J. Cancer Prev. 17(4), 354-357 (2008).
176. Bleiberg H, Autier P, Huet F et al.: Colorectal cancer (CRC) screening using sigmoidoscopy followed by colonoscopy: a feasibility and efficacy study on a cancer institute based population. Ann. Oncol. 17(8), 1328-1332 (2006).
177. Sewitch MJ, Fournier C, Ciampi A, Dyachenko A: Colorectal cancer screening in Canada: results of a national survey. Chronic Dis. Can. 29(1), 9-21 (2008).
178. Kronborg O, Fenger C, Olsen J, Jorgensen OD, Sondergaard O: Randomized study of screening for colorectal cancer with faecal-occult-blood test. Lancet 348(9040), 1467-1471 (1996).
179. Lachter J, Leska-Aharoni T, Warum D, Eliakim R: Overcoming barriers to colorectal cancer screening tests. Isr. Med. Assoc. J. 10(8-9), 621-626 (2008).
180. Hoff G, Bretthauer M: Appointments timed in proximity to annual milestones and compliance with screening: randomized controlled trial. Br. Med. J. 337, a2794 (2008).
181. Regula J, Rupinski M, Kraszewska E et al.: Colonoscopy in colorectal-cancer screening for detection of advanced neoplasia. N. Engl. J. Med. 355(18), 1863-1872 (2006).
182. Gutierrez-Ibarluzea I, Asua J, Latorre K: Policies of screening for colorectal cancer in European countries. Int. J. Technol. Assess. Health Care 24(3), 270-276 (2008).
183. von Karsa L, Anttila A, Ronco G et al.: Cancer screening in the European Union: Report on the implementation of the Council Recommendation on cancer screening. International Agency for Research on Cancer 1 (2008).
184. The UK National Bowel Cancer Screening Programme. Contains information about the structure of the programme, updates on roll-out, and access to various patient information leaflets (each of which is translated into 20 different languages) www.cancerscreening.nhs.uk/bowel/
185. The Australian National Cancer Screening website. This site contains links to three different screening programmes including breast, cervical and bowel www.cancerscreening.gov.au/
186. An interactive decision aid (login details = email: test; password: test) that has previously been used in an intervention and offers information about colorectal cancer, risk factors and screening http://colorectalweb.org/
187. The Prevent Cancer Foundation aims to fund research and offer public education about cancer and community outreach. The website contains updates on various events and activities organised by the Foundation and links to more interactive campaign websites (e.g. CONFESS!) www.preventcancer.org/colorectal/
188. Website specifically designed for healthcare professionals. It offers guidance on how to design comprehensive cancer control programs or plans, including a step-by-step guide and detailed information on various specific cancers, including colorectal cancer http://cancercontrolplanet.cancer.gov
189. Website providing information about the Scottish Bowel Cancer Screening Programme, including information about its organization, and a summary of findings gathered as part of the Scottish Bowel Cancer Screening Pilot www.isdscotland.org/isd/1696.html